Curium Receives Positive CHMP Opinion of PYLCLARI® for Primary Staging of Patients With High-Risk PCa Prior to Initial Curative Therapy and to Localize Recurrence of PCa in Patients With a Suspected Recurrence Based on Increasing Serum Prostate-Specific Antigen (PSA) Levels After Primary Treatment With Curative Intentnews2023-05-26T14:09:26+00:00May 26th, 2023|Medical Device News Magazine|
Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023news2023-05-26T13:49:32+00:00May 26th, 2023|Medical Device News Magazine|
Shuttle Pharmaceuticals Provides First Quarter 2023 Corporate Updatenews2023-05-26T13:46:12+00:00May 26th, 2023|Medical Device News Magazine|
Novavax’s Nuvaxovid ™ Receives Positive CHMP Opinion for Full Marketing Authorization for the Prevention of COVID in the EUnews2023-05-26T13:38:45+00:00May 26th, 2023|Medical Device News Magazine|
